Six of the genes that we identified, namely, BTK, Chka, Flt3, Kit, Pik3ca, and Tgfbr1 are the targets of anti-cancer drugs in current clinical trials (http://www.cancer.gov/drugdictionary). Here, KIT is linked to cancer.